Valid for Submission
R87.611 is a billable diagnosis code used to specify a medical diagnosis of atypical squamous cells cannot exclude high grade squamous intraepithelial lesion on cytologic smear of cervix (asc-h). The code R87.611 is valid during the fiscal year 2021 from October 01, 2020 through September 30, 2021 for the submission of HIPAA-covered transactions.
The ICD-10-CM code R87.611 might also be used to specify conditions or terms like abnormal cervical papanicolaou smear or atypical squamous cells on cervical papanicolaou smear cannot exclude high grade squamous intraepithelial lesion.
The code R87.611 is applicable to female patients only. It is clinically and virtually impossible to use this code on a non-female patient.
The code is commonly used in ob/gyn medical specialties to specify clinical concepts such as abnormal female genital cytology.
According to ICD-10-CM guidelines this code should not to be used as a principal diagnosis code when a related definitive diagnosis has been established.
Index to Diseases and Injuries
The Index to Diseases and Injuries is an alphabetical listing of medical terms, with each term mapped to one or more ICD-10 code(s). The following references for the code R87.611 are found in the index:
- - Abnormal, abnormality, abnormalities - See Also: Anomaly;
The Medicare Code Editor (MCE) detects and reports errors in the coding of claims data. The following ICD-10 Code Edits are applicable to this code:
The following clinical terms are approximate synonyms or lay terms that might be used to identify the correct diagnosis code:
- Abnormal cervical Papanicolaou smear
- Atypical squamous cells on cervical Papanicolaou smear cannot exclude high grade squamous intraepithelial lesion
Diagnostic Related Groups - MS-DRG Mapping
Convert R87.611 to ICD-9 Code
Information for Patients
Cervical Cancer Screening
The cervix is the lower part of the uterus, the place where a baby grows during pregnancy. Cancer screening is looking for cancer before you have any symptoms. Cancer found early may be easier to treat.
Cervical cancer screening is usually part of a woman's health checkup. There are two types of tests: the Pap test and the HPV test. For both, the doctor or nurse collects cells from the surface of the cervix. With the Pap test, the lab checks the sample for cancer cells or abnormal cells that could become cancer later. With the HPV test, the lab checks for HPV infection. HPV is a virus that spreads through sexual contact. It can sometimes lead to cancer. If your screening tests are abnormal, your doctor may do more tests, such as a biopsy.
Cervical cancer screening has risks. The results can sometimes be wrong, and you may have unnecessary follow-up tests. There are also benefits. Screening has been shown to decrease the number of deaths from cervical cancer. You and your doctor should discuss your risk for cervical cancer, the pros and cons of the screening tests, at what age to start being screened, and how often to be screened.
- Cervical cancer -- screening and prevention (Medical Encyclopedia)
- HPV DNA test (Medical Encyclopedia)
- Pap and HPV Testing - NIH (National Cancer Institute)
- Pap smear (Medical Encyclopedia)
[Learn More in MedlinePlus]